Developer docs
API playgroundTry for free, no card

Search company profiles

Amalgam Rx

Full company profile

uuid00009j8

Namestring
Amalgam Rx
Legal namestring
Amalgam Rx, Inc.
Websiteurl
amalgamrx.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Amalgam Rx is a US-based, private digital health company that operates a modular, AI-powered Software as a Medical Device (SaMD) platform delivering EHR-integrated clinical decision support, digital therapeutics, and conversational AI applications to life sciences companies, health plans, and provider organizations. The platform is anchored by a proprietary Medical-Grade AI™ layer (40+ clinical guardrails for MLR compliance, trained on 100B+ real-world healthcare knowledge points) and, more recently, the Chiron foundation model—an autoregressive transformer trained on millions of longitudinal patient records that predicts next medical events across therapeutic areas simultaneously. Core product lines include EHR Solutions (patient identification, clinical trial recruitment, care guidelines, financial assistance, medication safety, prior authorization), Digital Products (companion apps such as DoseCheck/iSage Rx for insulin titration and Elevmi for Alzheimer's caregiver support), and Enterprise Platform deployments for global life sciences and payer customers.

The company monetizes primarily through SaaS and platform licensing, per-provider EHR-integrated clinical decision support deployments, and co-development / commercialization agreements with life sciences partners (Novo Nordisk, Otsuka, Biolinq, Exact Sciences) under which it earns platform fees, development milestones, and royalties while acting as Manufacturer of Record for regulated SaMD across multiple geographies. Amalgam's solutions are embedded directly into the native UI/UX of every major US EHR (Epic, Cerner/Oracle Health, athenahealth, Veradigm, DrChrono, NextGen, Modernizing Medicine), with a stated 53-minute implementation window from contract to live. Named enterprise customers include Novo Nordisk, Otsuka Precision Health, Biolinq, Privia Health, Exact Sciences, Aetna (CVS Health), and Summit Medical Group-City MD, while the platform underpins products reaching nearly 10 million patients and 70M+ clinical decisions evaluated across four continents with FDA, CE Mark, and SFDA regulatory clearances.

The company is headquartered in Wilmington, Delaware, employs 51-100 people, and was founded by the former WellDoc founding team. Capital sources include a Series B led by CVS Health Ventures (Oct 2023), a strategic equity investment from Novo Nordisk, and a $20M senior secured term loan from Catalio Capital Management (Aug 2025). The Avhana Health and Geetha acquisitions expanded the EHR-anchored clinical decision support footprint and conversational AI / psychosocial engine capabilities, respectively. Compliance posture includes FDA 21 CFR Part 820, ISO 13485:2016, ISO 27001:2022, SOC 2 Type 2, HIPAA, and GDPR, with AWS as the underlying cloud infrastructure partner.

Short descriptiontext

Amalgam Rx operates a modular, AI-powered SaMD platform delivering EHR-integrated clinical decision support, digital therapeutics, and conversational AI to life sciences, payer, and provider customers across four continents.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWilmington, United States
HQ citystring
Wilmington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support, digital therapeutics, healthcare AI software, EHR integration solutions, software as medical device
Industry4 codes
PRIMARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Software Publishers5132
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Prepackaged Software7372
Product category
Digital Health Software / Healthcare AI SaMD Platform
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1SaaS Platform Licensing
TypeSubscription Recurring
Description

Amalgam Rx operates a SaaS-enabled digital marketplace and product platform that generates recurring licensing fees from life sciences companies, health plans, and provider organizations. The modular platform enables rapid solution creation and is licensed across brands, business units, geographies, and therapeutic areas.

amalgamrx.com
2EHR-Integrated Clinical Decision Support
TypeSubscription Recurring
Description

Clinical decision support solutions integrated into EHR workflows are provided to provider organizations, health plans, and life sciences companies, typically structured as per-provider or per-implementation licensing arrangements.

amalgamrx.com
3Digital Therapeutics (DTx) and Companion Products
TypeLicensing Royalties
Description

Amalgam develops and commercializes DTx and companion products with life sciences partners (e.g., DoseCheck with Novo Nordisk, Elevmi with Otsuka, Biolinq Shine app with Biolinq). Revenue flows through co-development agreements, commercialization milestones, and platform fees.

amalgamrx.com
4Enterprise Platform Deployment
TypeManaged Services
Description

Enterprise customers deploy Amalgam's platform across their organizations to unify patient, caregiver, and provider engagement on a single global foundation. Revenue is generated through platform fees, customization, and ongoing support.

amalgamrx.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1DoseCheck
Description

Digital insulin initiation and titration app for people with type 2 diabetes using basal insulin

amalgamrx.com
+5 more records
Core offering1 text field

Amalgam Rx develops and licenses a modular, AI-powered Software as a Medical Device (SaMD) platform that delivers EHR-integrated clinical decision support, digital therapeutics, and conversational Medical-Grade AI applications for life sciences companies, health plans, and provider organizations. Named offerings include Elevmi (Alzheimer's caregiver support), DoseCheck and iSage Rx (insulin titration), and Avhana Health (point-of-care clinical decision support), all powered by the proprietary Chiron foundation model and embedded directly into provider EHR workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Nearly 2x improvement in diagnostic efficiency for sleep apnea compared to traditional tools, reducing unnecessary diagnostic follow-ups by nearly half (Chiron foundation model)
+6 more records
Product overview1 text field

Amalgam Rx operates a modular, AI-powered Software as a Medical Device (SaMD) platform with three core solution pillars: Medical-Grade AI™ (conversational AI with healthcare-specific guardrails), EHR Solutions (integrated clinical decision support), and Digital Products (patient support applications). The Enterprise Platform serves as the unified foundation enabling deployment and scaling across brands, markets, and therapeutic areas. Individual products include Chiron (foundation model for predictive patient intelligence), Elevmi (Alzheimer's caregiver support), DoseCheck/iSage Rx (insulin titration), and Avhana Health (clinical decision support - acquired). The company also offers PDURS (Prescription Drug Use-Related Software) services. Solutions are integrated into leading EHRs including Epic, athenahealth, Cerner, and Veradigm, supporting nearly 10 million patients across four continents.

Product and service11 records
1Medical-Grade AI
CategoryAI Platform / Conversational AI
Description

Clinically tested conversational AI platform with built-in guardrails for healthcare applications, powering HCP, Patient, and Caregiver Assistants for life sciences companies, health plans, and providers.

2EHR Solutions
CategoryClinical Decision Support
Description

EHR-integrated point-of-care solutions enabling patient identification, clinical trial recruitment, care guidelines, financial assistance, medication safety, prior authorization, and quality measure improvement for provider organizations.

3Digital Products
CategoryDigital Therapeutics
Description

Patient support applications and Software as a Medical Device (SaMD) products co-developed with global life sciences companies to drive outcomes across diabetes, Alzheimer's, oncology, and other therapeutic areas.

4Enterprise Platform
CategoryEnterprise SaaS Platform
Description

Modular, AI-powered SaMD platform that enables enterprise customers to deploy and scale patient, caregiver, and provider engagement solutions across brands, business units, geographies, and therapeutic areas on a single global foundation.

5PDURS (Prescription Drug Use-Related Software)
CategoryPrescription Drug Use-Related Software
Description

Prescription Drug Use-Related Software solutions that support, improve, or supplement use of prescription medications, enabling FDA labeling differentiation for life sciences brand franchises.

6Elevmi
CategoryDigital Therapeutic / Caregiver Support App
Description

AI digital support application for caregivers of patients with Alzheimer's Disease, co-developed with Otsuka Precision Health and powered by Amalgam's Medical-Grade AI platform.

7DoseCheck
CategoryDigital Therapeutic / Insulin Titration
Description

Digital insulin initiation and titration app for people with type 2 diabetes on basal insulin, white-labeled from iSage Rx and integrated with Novo Nordisk's connected insulin delivery, CGM, and EHRs.

8iSage Rx
CategoryDigital Therapeutic / Insulin Titration
Description

Insulin titration application supporting titration of all basal insulins with connectivity to leading Bluetooth-enabled blood glucose meters, CE Marked for European market launch.

9Avhana Health CDS
CategoryClinical Decision Support
Description

Clinical decision support SaaS tool acquired by Amalgam Rx with deep EHR integrations, enabling providers to support real-time adoption of clinical quality guidelines and identify cost savings.

10Chiron Foundation Model
CategoryAI Foundation Model
Description

Proprietary foundation model for predictive patient intelligence that predicts medical events across multiple therapeutic areas simultaneously from a unified longitudinal patient journey, embedded within Amalgam's Medical-Grade AI platform.

11Biolinq Shine App
CategoryMedical Device Companion App
Description

Mobile app developed by Amalgam as the digital backbone for the Biolinq Shine needle-free, wearable glucose sensor integrating glucose, activity, and sleep data in a single device.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-03
Description

Privia Health, a national physician enablement company (NASDAQ: PRVA), partnered with Amalgam Rx for EHR-integrated clinical decision support and population health workflows. The collaboration achieved an 84% colorectal cancer screening rate in 2024, exceeding the National Colorectal Cancer Roundtable's 80% goal. The program engaged over 100,000 patients nationally, processed approximately 23,000 screening orders within 48 hours, and identified 550+ patients requiring diagnostic follow-up.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-03
Description

Exact Sciences Corp. (NASDAQ: EXAS) partnered with Amalgam Rx and Privia Health to integrate the Cologuard colorectal cancer screening test into EHR workflows for automated patient identification, engagement, and follow-up at population scale. The nationwide EHR-enabled outreach program achieved colorectal cancer screening rates outperforming national benchmarks while reducing staff workload.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

Amalgam Rx partnered with Biolinq to develop the digital infrastructure for Biolinq Shine™, the first FDA De Novo-cleared, needle-free glucose sensor. Amalgam's scalable software platform enabled rapid software development supporting Biolinq's regulatory timelines. The same architecture supports Biolinq's multi-analyte ambitions beyond glucose.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-07
Description

Amalgam Rx partnered with Otsuka Precision Health to launch Elevmi™, an AI-powered digital application helping caregivers support loved ones with Alzheimer's Disease. Amalgam provided its Medical-Grade AI platform and regulatory expertise; OPH provided brand and therapeutic area expertise. Elevmi is available on iOS and Android stores.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-12-19
Description

Amalgam Rx expanded its global agreement with Novo Nordisk for commercialization of DoseCheck (insulin titration app). Novo Nordisk also made an equity investment in Amalgam. The new agreement incorporated integration with connected insulin delivery devices, continuous glucose monitors, and EHRs. Global expansion followed, with launches in Europe, Asia, and South America.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-07-15
Description

Amalgam Rx collaborates with AWS for Health initiative to accelerate development and global commercialization of regulated digital solutions. Amalgam's platform runs on AWS using container-based serverless technologies, service control policies for security/regulatory compliance, and Infrastructure as Code with CI/CD practices. AWS supports GxP-compliant workloads and HIPAA requirements.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-07-15
Description

Epic is one of the major EHR systems with which Amalgam Rx has deep integration. Amalgam's solutions are embedded directly into the Epic EHR workflow for clinical decision support, patient identification, and other point-of-care tools.

8Cerner (Oracle Health)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-07-15
Description

Cerner (now Oracle Health) is a major EHR system with deep Amalgam Rx integration. Solutions are embedded into the Cerner EHR workflow for clinical decision support and population health management.

amalgamrx.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-07-15
Description

athenahealth is a major EHR platform integrated with Amalgam Rx's solutions. The Privia Health colorectal cancer screening program used athenaClinicals EHR for ordering, results delivery, and follow-up integration.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-07-15
Description

Veradigm (formerly Allscripts) is a major EHR system with Amalgam Rx integration for clinical decision support and point-of-care solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

WellDoc pioneered the FDA-cleared, clinically validated mobile prescription therapy space (BlueStar for type 2 diabetes) and was co-founded by Amalgam's founders, Ryan Sysko and Dr. Suzanne Clough. It directly overlaps Amalgam's insulin-titration DTx business (DoseCheck/iSage Rx) and provider-EHR-integrated chronic care.

TypeDirect peer
Description

Click Therapeutics develops prescription digital therapeutics with FDA clearance and pharma commercialization partnerships, most directly comparable to Amalgam's pharma-co-developed DTx and SaMD pipeline. Overlap is strongest in regulated software-as-medicine, pharma co-development, and life-sciences commercialization.

TypeDirect peer
Description

Akili develops FDA-cleared prescription digital therapeutics (EndeavorRx) and partners with pharma and providers on cognitive and behavioral interventions, making it a directly comparable DTx peer in regulatory pathway, evidence generation, and pharma commercialization model.

TypeDirect peer
Description

Voluntis (acquired by Otsuka in 2020) developed insulin titration and oncology DTx products including Oleena, directly competing with Amalgam's DoseCheck/iSage Rx franchise. As Otsuka now owns Voluntis, Amalgam's Elevmi partnership with Otsuka sits alongside a vertically integrated competing asset, sharpening the comparison.

TypeBroad incumbent
Description

Omada Health delivers digital chronic care (diabetes, hypertension, MSK) through payer and employer channels, comparable to Amalgam's life-sciences chronic-disease focus. Although broader in employer/ payer distribution, Omada overlaps heavily in diabetes and behavior-change digital therapeutics.

TypeBroad incumbent
Description

Health Catalyst provides data-and-analytics infrastructure for health systems, including clinical decision support, quality-measure improvement, and value-based care enablement — directly comparable to Amalgam's Avhana-acquired CDS workflow and EHR-integrated quality/savings tooling.

TypeBroad incumbent
Description

Doximity's workflow tools and physician-facing applications overlap with Amalgam's HCP Assistant and EHR-embedded point-of-care decision support, particularly in connecting clinical content and decision support to providers inside daily workflows.

TypeEmerging player
Description

Phreesia provides patient intake, eligibility, and clinical workflow tools integrated into major EHRs. The category overlap is around EHR-embedded patient identification, automated outreach, and quality-measure workflows (e.g., Phreesia's preventive screening modules), aligned with Amalgam's colorectal cancer screening execution.

TypeEmerging player
Description

Innovaccer offers EHR-integrated population health management, clinical decision support, and value-based care enabler tools across health systems and payers, comparable to Amalgam's EHR Solutions suite and Avhana CDS footprint at 150+ provider groups.

10Babylon Health
TypeOthers
Description

Babylon Health represented the AI-driven clinical decision/chatbot category that overlaps thematically with Amalgam's Medical-Grade AI conversational engine and Chiron's predictive intelligence, although its geographic and payer-partnership profile differs; useful as an adjacent AI-clinical benchmark.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration14 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Amalgam Rx

Digital Health Software / Healthcare AI SaMD Platformamalgamrx.com

Amalgam Rx operates a modular, AI-powered SaMD platform delivering EHR-integrated clinical decision support, digital therapeutics, and conversational AI to life sciences, payer, and provider customers across four continents.

What Amalgam Rx does

Amalgam Rx is a US-based, private digital health company that operates a modular, AI-powered Software as a Medical Device (SaMD) platform delivering EHR-integrated clinical decision support, digital therapeutics, and conversational AI applications to life sciences companies, health plans, and provider organizations. The platform is anchored by a proprietary Medical-Grade AI™ layer (40+ clinical guardrails for MLR compliance, trained on 100B+ real-world healthcare knowledge points) and, more recently, the Chiron foundation model—an autoregressive transformer trained on millions of longitudinal patient records that predicts next medical events across therapeutic areas simultaneously. Core product lines include EHR Solutions (patient identification, clinical trial recruitment, care guidelines, financial assistance, medication safety, prior authorization), Digital Products (companion apps such as DoseCheck/iSage Rx for insulin titration and Elevmi for Alzheimer's caregiver support), and Enterprise Platform deployments for global life sciences and payer customers.

The company monetizes primarily through SaaS and platform licensing, per-provider EHR-integrated clinical decision support deployments, and co-development / commercialization agreements with life sciences partners (Novo Nordisk, Otsuka, Biolinq, Exact Sciences) under which it earns platform fees, development milestones, and royalties while acting as Manufacturer of Record for regulated SaMD across multiple geographies. Amalgam's solutions are embedded directly into the native UI/UX of every major US EHR (Epic, Cerner/Oracle Health, athenahealth, Veradigm, DrChrono, NextGen, Modernizing Medicine), with a stated 53-minute implementation window from contract to live. Named enterprise customers include Novo Nordisk, Otsuka Precision Health, Biolinq, Privia Health, Exact Sciences, Aetna (CVS Health), and Summit Medical Group-City MD, while the platform underpins products reaching nearly 10 million patients and 70M+ clinical decisions evaluated across four continents with FDA, CE Mark, and SFDA regulatory clearances.

The company is headquartered in Wilmington, Delaware, employs 51-100 people, and was founded by the former WellDoc founding team. Capital sources include a Series B led by CVS Health Ventures (Oct 2023), a strategic equity investment from Novo Nordisk, and a $20M senior secured term loan from Catalio Capital Management (Aug 2025). The Avhana Health and Geetha acquisitions expanded the EHR-anchored clinical decision support footprint and conversational AI / psychosocial engine capabilities, respectively. Compliance posture includes FDA 21 CFR Part 820, ISO 13485:2016, ISO 27001:2022, SOC 2 Type 2, HIPAA, and GDPR, with AWS as the underlying cloud infrastructure partner.

Amalgam Rx firmographics

Firmographics
Name
Amalgam Rx
Legal name
Amalgam Rx, Inc.
Website
https://amalgamrx.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Amalgam Rx operates a modular, AI-powered SaMD platform delivering EHR-integrated clinical decision support, digital therapeutics, and conversational AI to life sciences, payer, and provider customers across four continents.
Ownership category
akta.pro rank

Amalgam Rx industry classification

Industry
Product category
Digital Health Software / Healthcare AI SaMD Platform
NAICS
Software Publishers (5132), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Clinical decision support
  • Digital therapeutics
  • Healthcare AI software
  • EHR integration solutions
  • Software as medical device

Where Amalgam Rx is headquartered

Location

Headquarters

HQ city
Wilmington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Amalgam Rx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS Platform Licensing: Amalgam Rx operates a SaaS-enabled digital marketplace and product platform that generates recurring licensing fees from life sciences companies, health plans, and provider organizations. The modular platform enables rapid solution creation and is licensed across brands, business units, geographies, and therapeutic areas.
  2. EHR-Integrated Clinical Decision Support: Clinical decision support solutions integrated into EHR workflows are provided to provider organizations, health plans, and life sciences companies, typically structured as per-provider or per-implementation licensing arrangements.
  3. Digital Therapeutics (DTx) and Companion Products: Amalgam develops and commercializes DTx and companion products with life sciences partners (e.g., DoseCheck with Novo Nordisk, Elevmi with Otsuka, Biolinq Shine app with Biolinq). Revenue flows through co-development agreements, commercialization milestones, and platform fees.
  4. Enterprise Platform Deployment: Enterprise customers deploy Amalgam's platform across their organizations to unify patient, caregiver, and provider engagement on a single global foundation. Revenue is generated through platform fees, customization, and ongoing support.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Amalgam Rx product offering

Product offering

Core offering

Amalgam Rx develops and licenses a modular, AI-powered Software as a Medical Device (SaMD) platform that delivers EHR-integrated clinical decision support, digital therapeutics, and conversational Medical-Grade AI applications for life sciences companies, health plans, and provider organizations. Named offerings include Elevmi (Alzheimer's caregiver support), DoseCheck and iSage Rx (insulin titration), and Avhana Health (point-of-care clinical decision support), all powered by the proprietary Chiron foundation model and embedded directly into provider EHR workflows.

Product overview

Amalgam Rx operates a modular, AI-powered Software as a Medical Device (SaMD) platform with three core solution pillars: Medical-Grade AI™ (conversational AI with healthcare-specific guardrails), EHR Solutions (integrated clinical decision support), and Digital Products (patient support applications). The Enterprise Platform serves as the unified foundation enabling deployment and scaling across brands, markets, and therapeutic areas. Individual products include Chiron (foundation model for predictive patient intelligence), Elevmi (Alzheimer's caregiver support), DoseCheck/iSage Rx (insulin titration), and Avhana Health (clinical decision support - acquired). The company also offers PDURS (Prescription Drug Use-Related Software) services. Solutions are integrated into leading EHRs including Epic, athenahealth, Cerner, and Veradigm, supporting nearly 10 million patients across four continents.

Differentiator

Problem solved

Functional benefit

Brands

  • DoseCheck: Digital insulin initiation and titration app for people with type 2 diabetes using basal insulin
  • iSage Rx
  • Elevmi
  • Chiron
  • Medical-Grade AI
  • Biolinq Shine

Products and services

  • Medical-Grade AI Clinically tested conversational AI platform with built-in guardrails for healthcare applications, powering HCP, Patient, and Caregiver Assistants for life sciences companies, health plans, and providers.
  • EHR Solutions EHR-integrated point-of-care solutions enabling patient identification, clinical trial recruitment, care guidelines, financial assistance, medication safety, prior authorization, and quality measure improvement for provider organizations.
  • Digital Products Patient support applications and Software as a Medical Device (SaMD) products co-developed with global life sciences companies to drive outcomes across diabetes, Alzheimer's, oncology, and other therapeutic areas.
  • Enterprise Platform Modular, AI-powered SaMD platform that enables enterprise customers to deploy and scale patient, caregiver, and provider engagement solutions across brands, business units, geographies, and therapeutic areas on a single global foundation.
  • PDURS (Prescription Drug Use-Related Software) Prescription Drug Use-Related Software solutions that support, improve, or supplement use of prescription medications, enabling FDA labeling differentiation for life sciences brand franchises.
  • Elevmi AI digital support application for caregivers of patients with Alzheimer's Disease, co-developed with Otsuka Precision Health and powered by Amalgam's Medical-Grade AI platform.
  • DoseCheck Digital insulin initiation and titration app for people with type 2 diabetes on basal insulin, white-labeled from iSage Rx and integrated with Novo Nordisk's connected insulin delivery, CGM, and EHRs.
  • iSage Rx Insulin titration application supporting titration of all basal insulins with connectivity to leading Bluetooth-enabled blood glucose meters, CE Marked for European market launch.
  • Avhana Health CDS Clinical decision support SaaS tool acquired by Amalgam Rx with deep EHR integrations, enabling providers to support real-time adoption of clinical quality guidelines and identify cost savings.
  • Chiron Foundation Model Proprietary foundation model for predictive patient intelligence that predicts medical events across multiple therapeutic areas simultaneously from a unified longitudinal patient journey, embedded within Amalgam's Medical-Grade AI platform.
  • Biolinq Shine App Mobile app developed by Amalgam as the digital backbone for the Biolinq Shine needle-free, wearable glucose sensor integrating glucose, activity, and sleep data in a single device.

Quantifiable outcome

  • Nearly 2x improvement in diagnostic efficiency for sleep apnea compared to traditional tools, reducing unnecessary diagnostic follow-ups by nearly half (Chiron foundation model)
  • +6 more outcomes

Companies that use Amalgam Rx

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Amalgam Rx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration14 records

AI capability9 records

Feature6 records

Amalgam Rx partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core.

  • Privia HealthcoreStrategic or Co-development Partner · 3 March 2026Privia Health, a national physician enablement company (NASDAQ: PRVA), partnered with Amalgam Rx for EHR-integrated clinical decision support and population health workflows. The collaboration achieved an 84% colorectal cancer screening rate in 2024, exceeding the National Colorectal Cancer Roundtable's 80% goal. The program engaged over 100,000 patients nationally, processed approximately 23,000 screening orders within 48 hours, and identified 550+ patients requiring diagnostic follow-up.
  • Exact Sciences Corp.coreStrategic or Co-development Partner · 3 March 2026Exact Sciences Corp. (NASDAQ: EXAS) partnered with Amalgam Rx and Privia Health to integrate the Cologuard colorectal cancer screening test into EHR workflows for automated patient identification, engagement, and follow-up at population scale. The nationwide EHR-enabled outreach program achieved colorectal cancer screening rates outperforming national benchmarks while reducing staff workload.
  • BiolinqcoreStrategic or Co-development Partner · 16 October 2025Amalgam Rx partnered with Biolinq to develop the digital infrastructure for Biolinq Shine™, the first FDA De Novo-cleared, needle-free glucose sensor. Amalgam's scalable software platform enabled rapid software development supporting Biolinq's regulatory timelines. The same architecture supports Biolinq's multi-analyte ambitions beyond glucose.
  • Otsuka Precision Health, Inc. (OPH)coreStrategic or Co-development Partner · 7 October 2024Amalgam Rx partnered with Otsuka Precision Health to launch Elevmi™, an AI-powered digital application helping caregivers support loved ones with Alzheimer's Disease. Amalgam provided its Medical-Grade AI platform and regulatory expertise; OPH provided brand and therapeutic area expertise. Elevmi is available on iOS and Android stores.
  • Novo NordiskcoreStrategic or Co-development Partner · 19 December 2022Amalgam Rx expanded its global agreement with Novo Nordisk for commercialization of DoseCheck (insulin titration app). Novo Nordisk also made an equity investment in Amalgam. The new agreement incorporated integration with connected insulin delivery devices, continuous glucose monitors, and EHRs. Global expansion followed, with launches in Europe, Asia, and South America.
  • Amazon Web Services (AWS)coreTechnology or Integration · 15 July 2021Amalgam Rx collaborates with AWS for Health initiative to accelerate development and global commercialization of regulated digital solutions. Amalgam's platform runs on AWS using container-based serverless technologies, service control policies for security/regulatory compliance, and Infrastructure as Code with CI/CD practices. AWS supports GxP-compliant workloads and HIPAA requirements.
  • EpiccoreTechnology or Integration · 15 July 2021Epic is one of the major EHR systems with which Amalgam Rx has deep integration. Amalgam's solutions are embedded directly into the Epic EHR workflow for clinical decision support, patient identification, and other point-of-care tools.
  • Cerner (Oracle Health)coreTechnology or Integration · 15 July 2021Cerner (now Oracle Health) is a major EHR system with deep Amalgam Rx integration. Solutions are embedded into the Cerner EHR workflow for clinical decision support and population health management.
  • athenahealthcoreTechnology or Integration · 15 July 2021athenahealth is a major EHR platform integrated with Amalgam Rx's solutions. The Privia Health colorectal cancer screening program used athenaClinicals EHR for ordering, results delivery, and follow-up integration.
  • VeradigmcoreTechnology or Integration · 15 July 2021Veradigm (formerly Allscripts) is a major EHR system with Amalgam Rx integration for clinical decision support and point-of-care solutions.

Scale indicators12 records

Recent moves6 records

Expansion highlights7 records

Amalgam Rx competitors and assessment

Company assessment

Direct peers

  • WellDoc: WellDoc pioneered the FDA-cleared, clinically validated mobile prescription therapy space (BlueStar for type 2 diabetes) and was co-founded by Amalgam's founders, Ryan Sysko and Dr. Suzanne Clough. It directly overlaps Amalgam's insulin-titration DTx business (DoseCheck/iSage Rx) and provider-EHR-integrated chronic care.
  • Click Therapeutics: Click Therapeutics develops prescription digital therapeutics with FDA clearance and pharma commercialization partnerships, most directly comparable to Amalgam's pharma-co-developed DTx and SaMD pipeline. Overlap is strongest in regulated software-as-medicine, pharma co-development, and life-sciences commercialization.
  • Akili Interactive: Akili develops FDA-cleared prescription digital therapeutics (EndeavorRx) and partners with pharma and providers on cognitive and behavioral interventions, making it a directly comparable DTx peer in regulatory pathway, evidence generation, and pharma commercialization model.
  • Voluntis: Voluntis (acquired by Otsuka in 2020) developed insulin titration and oncology DTx products including Oleena, directly competing with Amalgam's DoseCheck/iSage Rx franchise. As Otsuka now owns Voluntis, Amalgam's Elevmi partnership with Otsuka sits alongside a vertically integrated competing asset, sharpening the comparison.

Broad incumbents

  • Omada Health: Omada Health delivers digital chronic care (diabetes, hypertension, MSK) through payer and employer channels, comparable to Amalgam's life-sciences chronic-disease focus. Although broader in employer/ payer distribution, Omada overlaps heavily in diabetes and behavior-change digital therapeutics.
  • Health Catalyst: Health Catalyst provides data-and-analytics infrastructure for health systems, including clinical decision support, quality-measure improvement, and value-based care enablement — directly comparable to Amalgam's Avhana-acquired CDS workflow and EHR-integrated quality/savings tooling.
  • Doximity: Doximity's workflow tools and physician-facing applications overlap with Amalgam's HCP Assistant and EHR-embedded point-of-care decision support, particularly in connecting clinical content and decision support to providers inside daily workflows.

Emerging players

  • Phreesia: Phreesia provides patient intake, eligibility, and clinical workflow tools integrated into major EHRs. The category overlap is around EHR-embedded patient identification, automated outreach, and quality-measure workflows (e.g., Phreesia's preventive screening modules), aligned with Amalgam's colorectal cancer screening execution.
  • Innovaccer: Innovaccer offers EHR-integrated population health management, clinical decision support, and value-based care enabler tools across health systems and payers, comparable to Amalgam's EHR Solutions suite and Avhana CDS footprint at 150+ provider groups.

Others

  • Babylon Health: Babylon Health represented the AI-driven clinical decision/chatbot category that overlaps thematically with Amalgam's Medical-Grade AI conversational engine and Chiron's predictive intelligence, although its geographic and payer-partnership profile differs; useful as an adjacent AI-clinical benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Amalgam Rx social profiles

Digital presence

Amalgam Rx compliance and trust

Trust signal

Compliance9 records

Amalgam Rx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Amalgam Rx leadership team

Management profile

Number of profiles

Profiles10 records

Amalgam Rx subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Amalgam Rx funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Amalgam Rx M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amalgam Rx

What does Amalgam Rx do?

Amalgam Rx develops and licenses a modular, AI-powered Software as a Medical Device (SaMD) platform that delivers EHR-integrated clinical decision support, digital therapeutics, and conversational Medical-Grade AI applications for life sciences companies, health plans, and provider organizations. Named offerings include Elevmi (Alzheimer's caregiver support), DoseCheck and iSage Rx (insulin titration), and Avhana Health (point-of-care clinical decision support), all powered by the proprietary Chiron foundation model and embedded directly into provider EHR workflows.

Is Amalgam Rx a public or private company?

Amalgam Rx is a private company. It is classified as venture growth investor backed and is currently operating.

When was Amalgam Rx founded?

Amalgam Rx was founded in 2009. It employs 51 to 100 people.

Where is Amalgam Rx based?

Amalgam Rx is headquartered in Wilmington, United States, in the North America region.

How does Amalgam Rx make money?

Four revenue lines are on record. SaaS Platform Licensing is the primary driver. The others are EHR-Integrated Clinical Decision Support, digital Therapeutics (DTx) and Companion Products and enterprise Platform Deployment.

Who are Amalgam Rx's main competitors?

Direct peers on record are WellDoc, Click Therapeutics, Akili Interactive and Voluntis. Broad incumbents are Omada Health, Health Catalyst and Doximity. Emerging players are Phreesia and Innovaccer. Babylon Health is listed as an others.

Does Amalgam Rx have an API?

No public API is recorded for Amalgam Rx.

What industry is Amalgam Rx in?

Amalgam Rx's product category is Digital Health Software / Healthcare AI SaMD Platform. Its primary akta.pro industry code is HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement, with a secondary code of HLACAAAN, EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps. Its NAICS code is 5132 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
University of Miami News and EventsMiller School Researchers Help Advance Award-Winning AI Model for Predictive Health CareThe University of Miami Miller School of Medicine has partnered with health technology company Amalgam Rx to advance Chiron, an AI model designed to analyze patients' complete medical histories for earlier disease detection and personalized treatment. The collaboration recently earned national recognition when Chiron was named "Overall Large Language Model of the Year" at the 2026 AI Breakthrough Awards, a global competition that received over 5,000 nominations from more than 20 countries. Researchers are now working to establish evidence-based frameworks for responsibly integrating AI into healthcare systems, with initial applications focused on sleep apnea detection before expanding to additional clinical use cases.Business Wire BlogAmalgam Rx Wins “Overall Large Language Model of the Year”AI Breakthrough Awards named Amalgam Rx the winner of the "Overall Large Language Model of the Year" award for its foundation model Chiron, which uses longitudinal patient data to predict medical events across therapeutic areas. Chiron demonstrated nearly 2x improvement in diagnostic efficiency for sleep apnea compared to traditional tools, reducing unnecessary follow-ups by nearly half. The award, part of the ninth annual AI Breakthrough Awards program that received over 5,000 nominations from more than 20 countries, recognizes innovation in healthcare AI architecture and clinical integration.FinancialContent Business PageAmalgam Rx Wins “Overall Large Language Model of the Year”Amalgam Rx, Inc. won the "Overall Large Language Model of the Year" award at the 2026 AI Breakthrough Awards for its foundation model Chiron, which provides predictive patient intelligence for healthcare by predicting medical events across multiple therapeutic areas simultaneously. Chiron demonstrated nearly 2x improvement in diagnostic efficiency for sleep apnea compared to traditional tools, reducing unnecessary diagnostic follow-ups by nearly half. The award, which attracted over 5,000 nominations from companies across more than 20 countries, recognizes Amalgam's Medical-Grade AI platform designed to be embedded in EHR workflows across major health systems.LinkedInAkash Desai - PaymanCatalio Capital Management invested £20 million (approximately $20 million) in Amalgam Rx, a Wilmington, Delaware-based digital therapeutics company, with the first $12 million already drawn. Amalgam Rx operates an FDA-cleared, CE-marked Software-as-a-Medical-Device platform integrated into electronic health record systems, serving nearly 10 million patients and powering over 70 million clinical decisions. The funding will be used to refinance debt, scale deployments, and leverage Catalio's advisory network of 45+ venture partners as the company expands its global footprint across four continents.Stock TitanExact Sciences program lifts colorectal screening to 84%Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. announced results from a colorectal cancer screening program that achieved an 84% screening rate in 2024, exceeding the National Colorectal Cancer Roundtable's 80% goal. The program engaged over 42,000 patients through automated outreach and processed approximately 23,000 screening orders within a 48-hour window. The collaboration demonstrates how EHR-integrated workflows and AI-powered patient engagement can improve cancer screening outcomes at population scale.Pulse 2.0Catalio Closes Structured Opportunities Fund II With Over $325 Million For Healthcare Structured CreditCatalio Capital Management has closed its second credit fund, Catalio Structured Opportunities Fund II, raising over $325 million, which surpassed its initial fundraising target. The fund aims to provide commercial-stage healthcare companies with tailored capital solutions, focusing on alternatives to traditional equity financing. Recent investments include $20 million in Leo Cancer Care and $20 million in Amalgam Rx to support their innovative healthcare projects.Alternative Credit InvestorCatalio raises $325m at close of second healthcare credit fundCatalio Capital Management has successfully closed its second healthcare credit fund, raising over $325 million and surpassing its $250 million target. The fund aims to provide flexible capital to commercial-stage healthcare companies and has already made 21 investments, including notable contributions to Leo Cancer Care and Amalgam Rx.PharmiWeb.comAmalgam Rx Partners with Biolinq -- Lighting Pathways to Better HealthAmalgam Rx partnered with Biolinq to develop the digital platform for Biolinq Shine, an FDA De Novo–cleared needle-free glucose sensor. The collaboration enabled rapid software development for regulatory submission, and the same architecture will support Biolinq's multi-analyte expansion.AI InsiderAmalgam Rx Secures $20M Credit Investment from Catalio Capital Management to Accelerate Medical-Grade AI™ DeploymentAmalgam Rx secured a $20 million credit investment from Catalio Capital Management, with an initial $12 million draw to support market expansion and refinance debt. The funding will accelerate its Medical-Grade AI platform, which supports nearly 10 million patients and over 70 million clinical decisions.